Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A8KL
|
|||
| Drug Name |
Benzoheterocyclic compound 1
|
|||
| Synonyms |
PMID28594589-Compound-TABLE3c5
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
Shanghai Kechow Pharma
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H18BrClFN3O4S2
|
|||
| Canonical SMILES |
C1CC1(CC(CO)O)S(=O)(=O)NC2=CC3=C(C(=C2NC4=C(C=C(C=C4)Br)Cl)F)N=CS3
|
|||
| InChI |
1S/C19H18BrClFN3O4S2/c20-10-1-2-13(12(21)5-10)24-17-14(6-15-18(16(17)22)23-9-30-15)25-31(28,29)19(3-4-19)7-11(27)8-26/h1-2,5-6,9,11,24-27H,3-4,7-8H2
|
|||
| InChIKey |
AITYBOUARXLEQK-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | ERK activator kinase (MEK) | Target Info | Inhibitor | [1] |
| Target's Patent Info | ERK activator kinase (MEK) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | MEK inhibitors in oncology: a patent review (2015-Present).Expert Opin Ther Pat. 2017 Aug;27(8):887-906. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.